Welwyn Garden City, UK – 21st January 2013 – Cresset, innovative provider of computational chemistry software and consulting services, announces excellent 2012 sales figures and growth.
Dr Robert Scoffin, CEO of Cresset, says, “We are delighted to announce robust growth through 2012 in both our software and services divisions. We have invested in the rebranding of our software tools and now have an even more professional software workbench for medicinal and computational chemists. This is complemented by our growing Consulting Services division, including the first full year of operation of our innovative CompChem on demand service.”
“The breadth and range of consulting projects that Cresset undertakes demonstrates the power and scope of Cresset’s underlying patented technology,” says Dr Martin Slater, Head of Consulting. “We have completed consulting projects this year on research areas as diverse as virtual screening against a novel rheumatoid arthritis target and discovery of new sweeteners for a global drinks manufacturer.”
Dr Scoffin adds, “As companies increasingly choose to outsource computational chemistry in order to take advantage of just-in-time expertise, we expect Cresset to continue to enjoy outstanding growth throughout and beyond 2013.”